Why Choose Auburn Pharmaceutical?

  • No Contracts!
  • Hassle Free Return Policy
  • Great Savings on Short Date Items
  • Great Value on Close-out Items
  • Free Shipping (orders of $75 or more)
  • Over 3,000 AB Rated Generics
  • Fully Accredited
  • VAWD Accredited

Auburn Pharmaceutical has become one of the fastest growing generic distributors in the country. We proudly serve over 2,500 independent pharmacies, chains, hospitals and governmental agencies.

Auburn Pharmaceutical is a family-owned and operated business, established in 1993. The family has been involved in the generic pharmaceutical industry for over 45 years.

See why Auburn Pharmaceutical is "DIFFERENT" from the rest. Register and get started today!

"I have had superb experience with Auburn, especially with our rep, due to the company's general values, deals and personal ability"
Ryan from Wisconsin

"Auburn is very competitive with pricing as well as great customer service. The sales rep I have is personable and courteous"
Jay from Kentucky

"It has been a very positive, professional and enjoyable experience dealing with the company and particularly our rep, she's a delight"
Camille from Ohio

"Ordering through Auburn has always been an easy experience. The staff is friendly with no pressure to buy, but knowledgeable on specials and upcoming shortages."
Lorraine from Michigan

Dr. Reddy's launches generic Antara capsules

Dr. Reddy's Labs on Wednesday announced the launch of fenofibrate capsules, USP in 43-mg and 130-mg strengths. The drug is the generic version of Antara (fenofibrate) capsules.

Wednesday April 23, 2014

Remington College Nashville Campus begins enrollment for new pharmacy tech program

Remington College Nashville Campus has started the process of enrolling students for its new Pharmacy Technician diploma program. The program incorporates a realistic pharmacy environment and a hands-on curriculum to help prepare students interested in pursuing entry-level jobs in the pharmacy field.

read more

Wednesday April 23, 2014

Bayer HealthCare gains orphan drug designation for investigational Ciprofloxacin Dry Powder

Bayer HealthCare on Tuesday announced that the Food and Drug Administration's Office of Orphan Products Development has granted orphan drug designation for Bayer's investigational Ciprofloxacin Dry Powder for Inhalation (Ciprofloxacin DPI) for the treatment of non-cystic fibrosis bronchiectasis.

read more

Wednesday April 23, 2014

Cefaly makes Rx medical device for the preventive treatment of migraine headaches available online

Cefaly Technology announced Wednesday that the Cefaly medical device for the preventive treatment of migraine headaches is available for purchase and delivery in the United States for patients with a medical prescription at Cefaly.us.

read more

Wednesday April 23, 2014